References
1. Oz SG, Fentoglu O, Kilicarslan A, et al. Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med J 2007;100:686–691.
2. Hujoel PP. Does chronic periodontitis cause coronary heart disease? A review of the literature. J Am Dent Assoc 2002;133(Suppl):31S–36S.
3. Holmlund A, Holm G, Lind L. Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects.J Periodontol 2006;77:1173–1178.
4. Desvarieux M, Demmer RT, Rundek T, et al. Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 2003;34:2120–2125.
5. D’Aiuto F, Graziani F, Tete’ S, et al. Periodontitis: from local infection to systemic diseases. Int J Immunopathol Pharmacol 2005;18(3 Suppl):1–12.
6. Padilla C, Lobos O, Hubert E, et al. Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J Periodontal Res 2006;41:350–353.
7. Lösche W, Karapetow F, Pohl A, et al. Plasma lipids and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000;27:537–541.
8. Mattila KJ, Pussinen PJ, Paju S. Dental infections and cardiovascular diseases: a review. J Periodontol 2005;76(11 Suppl):2085–2088.
9. Beck JD, Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005;76(11 Suppl):2089–2100.
10. Lösche W, Marshal GJ, Apatzidou DA, et al. Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 2005;32:640–644.
11. Seinost G, Wimmer G, Skerget M, et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 2005;149:1050–1054.
12. D’Aiuto F, Parkar M, Nibali L, et al. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006;151:977–984.
13. Thomas HE Jr, Kannel WB, Dawber TR, et al. Cholesterol-phospholipid ratio in the prediction of coronary heart disease: the Framingham study. N Engl J Med 1966;274:701–705.
14. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002;105:310–315.